Nutex Health Debt to Equity Ratio 2016-2025 | NUTX
Current and historical debt to equity ratio values for Nutex Health (NUTX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Nutex Health debt/equity for the three months ending September 30, 2025 was 0.67.
| Nutex Health Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-09-30 | $0.53B | $0.44B | 1.20 |
| 2025-06-30 | $0.50B | $0.34B | 1.50 |
| 2025-03-31 | $0.51B | $0.26B | 1.99 |
| 2024-12-31 | $0.47B | $0.19B | 2.48 |
| 2024-09-30 | $0.36B | $0.08B | 4.50 |
| 2024-06-30 | $0.34B | $0.08B | 4.15 |
| 2024-03-31 | $0.32B | $0.08B | 4.05 |
| 2023-12-31 | $0.32B | $0.08B | 4.03 |
| 2023-09-30 | $0.38B | $0.11B | 3.57 |
| 2023-06-30 | $0.33B | $0.11B | 3.03 |
| 2023-03-31 | $0.32B | $0.11B | 2.93 |
| 2022-12-31 | $0.31B | $0.12B | 2.59 |
| 2022-09-30 | $0.30B | $0.13B | 2.28 |
| 2022-06-30 | $0.31B | $0.57B | 0.54 |
| 2022-03-31 | $0.01B | $0.07B | 0.14 |
| 2021-12-31 | $0.20B | $0.19B | 1.06 |
| 2021-09-30 | $0.01B | $0.07B | 0.13 |
| 2021-06-30 | $0.01B | $0.07B | 0.15 |
| 2021-03-31 | $0.05B | $0.07B | 0.75 |
| 2020-12-31 | $0.00B | $0.00B | -1.15 |
| 2020-09-30 | $0.00B | $0.01B | 0.30 |
| 2020-06-30 | $0.00B | $0.01B | 0.25 |
| 2020-03-31 | $0.00B | $0.00B | 2.56 |
| 2019-12-31 | $0.01B | $0.00B | 2.60 |
| 2019-09-30 | $0.00B | $0.00B | 2.29 |
| 2019-06-30 | $0.00B | $0.00B | 1.31 |
| 2019-03-31 | $0.00B | $0.00B | 1.00 |
| 2018-12-31 | $0.00B | $0.00B | -1.30 |
| 2018-09-30 | $0.00B | $0.00B | 0.78 |
| 2018-06-30 | $0.00B | $0.00B | 0.60 |
| 2018-03-31 | $0.00B | $0.00B | 0.50 |
| 2017-12-31 | $0.00B | $0.00B | 0.41 |
| 2017-09-30 | $0.00B | $0.01B | 0.13 |
| 2017-06-30 | $0.00B | $0.01B | 0.10 |
| 2017-03-31 | $0.00B | $0.00B | 0.00 |
| 2016-12-31 | $0.01B | $-0.01B | -1.09 |
| 2016-09-30 | $0.00B | $0.00B | 0.00 |
| 2016-06-30 | $0.00B | $0.00B | 0.00 |
| 2016-03-31 | $0.00B | 0.00 | |
| 2015-12-31 | $0.00B | 0.00 | |
| 2015-09-30 | $0.00B | 0.00 | |
| 2015-06-30 | $0.00B | 0.00 | |
| 2015-03-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.743B | $0.480B |
| Nutex Health Inc. is a physician-led, technology-enabled healthcare services company. The Company's operating divisions include Hospital division and Population Health Management division. Hospital division implements and operates different health care models, including micro hospitals, specialty hospitals and hospital outpatient departments. Population Health Management division owns and operates provider networks such as Independent Physician Associations. Nutex Health Inc., formerly known as Clinigence Holdings Inc., is based in HOUSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $151.823B | 27.56 |
| HCA Healthcare (HCA) | United States | $119.687B | 18.94 |
| CVS Health (CVS) | United States | $99.143B | 11.55 |
| Elevance Health (ELV) | United States | $74.166B | 11.14 |
| Cencora (COR) | United States | $68.103B | 21.49 |
| Natera (NTRA) | United States | $28.748B | 0.00 |
| Labcorp Holdings (LH) | United States | $23.055B | 17.58 |
| DiDi Global (DIDIY) | China | $21.650B | 20.00 |
| Viatris (VTRS) | United States | $18.186B | 6.78 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.455B | 0.00 |
| BioMerieux (BMXMF) | France | $13.324B | 0.00 |
| Solventum (SOLV) | United States | $13.173B | 12.79 |
| Medpace Holdings (MEDP) | United States | $11.808B | 27.19 |
| CochLear (CHEOY) | Australia | $11.290B | 0.00 |
| Revvity (RVTY) | United States | $10.835B | 18.85 |
| Charles River Laboratories (CRL) | United States | $7.812B | 15.05 |
| Sonic Healthcare (SKHHY) | Australia | $7.666B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $6.816B | 40.63 |
| ICON (ICLR) | Ireland | $6.467B | 6.42 |
| HealthEquity (HQY) | United States | $6.255B | 23.39 |
| Avantor (AVTR) | United States | $6.234B | 10.04 |
| PACS (PACS) | United States | $6.094B | 37.06 |
| Bausch + Lomb (BLCO) | Canada | $5.927B | 38.91 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.826B | 0.00 |
| Sotera Health (SHC) | United States | $4.821B | 23.25 |
| Alignment Healthcare (ALHC) | United States | $4.012B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.062B | 19.11 |
| GeneDx Holdings (WGS) | United States | $2.621B | 46.03 |
| Establishment Labs Holdings (ESTA) | United States | $2.137B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.004B | 25.82 |
| Organon (OGN) | United States | $1.835B | 2.06 |
| Pediatrix Medical (MD) | United States | $1.809B | 10.81 |
| Progyny (PGNY) | United States | $1.809B | 35.56 |
| Ardent Health (ARDT) | United States | $1.357B | 4.43 |
| InnovAge Holding (INNV) | United States | $1.133B | 167.00 |
| CareDx (CDNA) | United States | $0.982B | 16.05 |
| Teladoc Health (TDOC) | United States | $0.793B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.740B | 12.11 |
| Omada Health (OMDA) | United States | $0.650B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.638B | 0.00 |
| Embecta (EMBC) | United States | $0.592B | 3.30 |
| Enhabit (EHAB) | United States | $0.568B | 25.50 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.562B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.475B | 8.74 |
| CryoPort (CYRX) | United States | $0.413B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Strata Critical Medical (SRTA) | United States | $0.380B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.364B | 5.86 |
| So-Young (SY) | China | $0.348B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.283B | 0.00 |
| Oncology Institute (TOI) | United States | $0.235B | 0.00 |
| Agilon Health (AGL) | United States | $0.151B | 0.00 |
| LifeMD (LFMD) | United States | $0.135B | 0.00 |
| Beauty Health (SKIN) | United States | $0.133B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.104B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.100B | 0.00 |
| Biodesix (BDSX) | United States | $0.086B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.075B | 0.00 |
| DocGo (DCGO) | United States | $0.069B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.039B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Pomdoctor - (POM) | China | $0.024B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.019B | 5.69 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |